Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: Efficacy of the "ex vivo" synergism method

Journal of Chemotherapy

Volumn 16, Issue 4, 2004, Pages 400-403

  Tascini, C ^a,b   Doria, R ^a   Leonildi, A ^a   Martinelli, C ^a   Menichetti, F ^a  

^a University Hospital in Pisa   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Ampicillin; Ceftriaxone; Endocarditis; Enterococcus faecalis endocarditis

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFTRIAXONE; GENTAMICIN; NETILMICIN; PENICILLIN G; STREPTOMYCIN; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIOSTASIS; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; DRUG POTENTIATION; DRUG SENSITIVITY; ENTEROCOCCUS FAECALIS; EX VIVO STUDY; HEART VALVE PROSTHESIS; HUMAN; INFECTION PREVENTION; MALE; MINIMUM INHIBITORY CONCENTRATION; SERUM BACTERICIDAL ACTIVITY;

EID: 3943109487     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.4.400     Document Type: Article

References (15)

1. Wilson WR, Karchmer AW, Dajani A et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA 1995; 274:1706-1713.
2. Horodniceanu T, Bougueleret L, El-Solh N, Bieth G, Delbos F, High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes. Antimicrob Agents Chemother 1979; 16: 686-689.
3. Cercenado E, Eliopoulos GM, Wennersten CB, Moellering RC, Jr. Influence of high-level gentamicin resistance and beta-haemolysis on susceptibility of enterococci to the bactericidal activities of ampicillin and vancomycin. Antimicrob Agents Chemother 1992; 36: 2526-2528.
4. Eliopoulos GM, Wennersten C, Zighelboim-Daum S, Reiszner S, Goldman F, Moellering RC, Jr. High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium. Antimicrob Agents Chemother 1988; 32: 1528-1532.
5. Eliopoulos GM. Antibiotic resistance in Enterococcus species: an update. In J.S. Remington, and M.N. Swartz (ed.), Current clinical topics in infectious diseases. Boston, Mass: Blackwell Science, Inc., 1996: 21-51.
6. Mainardi JL, Gutmann L, Acar F, Goldstein FW. Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis. Antimicrob Agents Chemother 1995; 39: 1984-1987.
7. Gavalda J, Torres C, Tenorio C et al. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides. Antimicrob Agents Chemother 1999; 43: 639-646.
8. Venditti M, Brandimarte C, Capone A, et al. Endocarditis caused by an Enterococcus faecalis high-level resistant to aminoglycosides: failure of ampicillin and ceftriaxone combined therapy. Clin Microbiol Infect 1997; 3: 577-80.
9. Gavalda in Program and abstract of the sixth International symposium on modern concepts in endocarditis and cardiovascular infections, Sitges, Spain, 2001.
10. Tascini C, Tagliaferri E, Iapoce R, Leonildi A, Menichetti F. Caspofungin in combination with itraconazole and amphotericin B for the treatment of invasive Aspergillosis in humans, with a method to test ex vivo synergism. Clin Microbiol Infect 2003; 9: 901-2.
11. Tascini C, Gemignani G, Leonildi A, Menichetti F. "Ex vivo" synergism: a method to optimise antimicrobial combinations for difficult-to-treat enterococcal endocarditis. J Chemother 2003; 15: 613-5.
12. th ed. Document M7-A4. National Committee for Clinical Laboratory Standards, Villanova, PA. 1997.
13. National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents. Approved guideline. Document M26-P. National Committee for Clinical Laboratory Standards, Villanova, Pa. 1987.
14. National Committee for Clinical Laboratory Standards. Methodology for the serum bactericidal test. Document M-21A. National Committee for Clinical Laboratory Standards, Villanova, PA. 1999.
15. Rice LB, Calderwood SB, Eliopoulos GM, Farber BF, Karchmer AW. Enterococcal endocarditis: a comparison of prosthetic and native valve diseases. Rev Infect Dis 1991; 13: 1-7.